Carcinoma in situ of the breast is a type of breast cancer that is confined to the ducts or lobules of the breast and has not spread to surrounding tissues. This type of breast cancer is also known as non-invasive breast cancer, and it is the earliest stage of breast cancer.
There are two types of carcinoma in situ of the breast: ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). DCIS is the most common type of carcinoma in situ of the breast, accounting for approximately 80% of all cases. LCIS is less common, accounting for approximately 20% of all cases.
The exact causes of carcinoma in situ of the breast are not fully understood. However, certain risk factors have been identified, including age, family history of breast cancer, early onset of menstruation, late onset of menopause, and exposure to radiation.
Carcinoma in situ of the breast does not typically cause any symptoms. It is usually detected during a mammogram or breast biopsy.
Treatment for carcinoma in situ of the breast usually involves surgery to remove the affected tissue. In most cases, a lumpectomy is performed, which involves removal of the affected area of the breast tissue. In some cases, a mastectomy may be necessary. Radiation therapy may also be recommended to destroy any remaining cancer cells.
Carcinoma in situ of the breast is an early stage of breast cancer that is confined to the ducts or lobules of the breast and has not spread to surrounding tissues. It is typically detected during a mammogram or breast biopsy and does not usually cause any symptoms. Treatment for carcinoma in situ of the breast usually involves surgery to remove the affected tissue, followed by radiation therapy to destroy any remaining cancer cells.
Not Available